
European Journal of Medicinal Chemistry p. 957 - 967 (1998)
Update date:2022-08-04
Topics:
Caliendo, Giuseppe
Grieco, Paolo
Perissutti, Elisa
Santagada, Vincenzo
Santini, Antonello
Albrizio, Stefania
Fattorusso, Caterina
Pinto, Aldo
Sorrentino, Raffaella
With the aim of discovering new molecules with K+-channel activating properties, we have synthesized derivatives of cromakalim (CRK), an important molecule which shows specific affinity towards K+ channels, by replacing the benzopyrane ring of this reference compound with a 1,4-benzoxazine moiety. A different number of substituents showing a good discrimination between hydrophobic and electronic properties have been inserted at the 6-position of the 1,4-benzoxazine ring. We describe here the synthesis and discuss the solid state conformation of these new molecules. When tested on rat aorta ring precontracted with phenylephrine, two compounds (2c and 2d) showed a concentration-dependent relaxation similar to that measured for cromakalim but less potent than this reference drug.
View MoreLaizhou City Laiyu Chemical CO.,Ltd
Contact:+86-535-2719337/2719339
Address:Chenggang road zhuyou laizhou City Shangdong China
Nanjing Habo Medical Technology Co., Ltd.
Contact:025-85769882
Address:No.108. Ganjiabian east. Qixia District .Nanjing
Contact:0086 371 65711996
Address:Jalan 4/3, Kawasan Perindustrian Serendah, 48000 Rawang,
Shaanxi King Stone Enterprise Company Limited
Contact:86-29-88353805,13609285751
Address:.209 Keji Road Hi-Tech industrial Develpment Zone .Xian China
Contact:0086-29-88315623
Address:S711, Innovation Bldg No.25 Gaoxin 1st Rd, Xian P.R of China 710075
Doi:10.1021/jo00838a036
(1969)Doi:10.1071/CH9951873
(1995)Doi:10.1016/0040-4039(95)01518-3
(1995)Doi:10.1021/om950574q
(1996)Doi:10.1021/ja00151a030
(1995)Doi:10.1055/s-2006-942359
(2006)